<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Clinical Neuroscience</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/570C2884-4776-4671-8B49-966FC4378AA1"><gtr:id>570C2884-4776-4671-8B49-966FC4378AA1</gtr:id><gtr:firstName>Claire</gtr:firstName><gtr:surname>Troakes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/05BF89CB-F4A6-4BD3-A566-CA7B0792F3B4"><gtr:id>05BF89CB-F4A6-4BD3-A566-CA7B0792F3B4</gtr:id><gtr:firstName>Safa</gtr:firstName><gtr:surname>Al-Sarraj</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FL016397%2F1"><gtr:id>567D35DB-226B-4E5B-8DA4-DD4B8BD8AC16</gtr:id><gtr:title>MRC Brain Banks: Joint Application to Underpin Neuroscience Research</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/L016397/1</gtr:grantReference><gtr:abstractText>This application plans to support research into the causes and potential treatment of a range of diseases affecting the
brain, some of which have been identified as priorities for research, such as dementia. The UK has a network of
established Brain Banks that provide human tissue samples to a wide range of researchers. Human tissue samples have
allowed a better understanding of the mechanisms operating in these complex disorders and have already aided the
development of treatments for Alzheimer's disease and Parkinson's disease.
This application will support four Brain Banks in Edinburgh, London, Newcastle and Oxford. These banks each have areas
of particular interest, Parkinson's disease, Alzheimer's disease and motor neurone disease. However, in addition to the
collection of tissues samples from patients with brain disorders, it is also essential to collect normal tissue samples for use
as controls in research. Two of the Banks have a major focus in this area, so this application will support the collection of
both disease and normal tissue samples.
The banks will support scientific research by providing human tissue samples in an efficient and cost effective manner,
while ensuring the samples provided are of the high quality required by researchers. The banks have worked to improve
their efficiency, reducing the time required to provide the samples to researchers. Details of the samples available in each
of the banks are included in a database, which is accessible through the internet. This allows researchers to see what
samples are available and how to request these samples for their research in an easy way that will save time and speed up
progress.
All four Brain Banks in this application have approval form an Ethics Committee, to ensure that their working practices meet
nationally agreed standards that apply to work with human tissue samples. The work of each Bank is overseen by a local
steering committee that includes members of the public and ethics experts as well as scientists and pathologists. Brain
Banking is expensive, but the operating costs of these four banks are far less than their equivalents in Europe and in the
USA.
The challenges of developing treatments for complex diseases such as Alzheimer's disease and Parkinson's disease are
considerable, but the Brain Banks in this application will play an important role in underpinning the scientific research in these national priority areas.</gtr:abstractText><gtr:technicalSummary>This joint application from the MRC Brain Banks in Edinburgh, London, Newcastle and Oxford is submitted in accordance
with the wishes of the MRC Neuroscience and Mental Health Board (NMHB). After the last funding round for the MRC
Brain Banks in 2011, NMHB indicated that a future joint application would be preferred and that the applicants should
demonstrate progress in efficiency and improving standards of work in accordance with an agreed set of metrics. This
application fulfils this request, and aims to underpin neuroscience research in the UK by providing high-quality human brain
tissue samples and data in the formats required by researchers in both academic and industrial settings. The four banks in
this application together cover the collection of human tissue samples from a range of major neurological diseases, and
normal tissue samples to act as controls. This provides an invaluable resource to underpin neuroscience research in UK,
particularly in recently identified priority areas such as dementia. The banks have demonstrated in this application that they can work to the standards set in the metrics agreed with the
NMHB, and have improved their efficiency of operations. The banks already support a number of major researchers in 
academia and industry in UK and overseas, including several who are currently funded by MRC. The provision of high
quality tissue samples and accompanying data is essential for the success of these projects; the MRC brain banks
constitute a critical infrastructure for this research. In order to develop this important work further, funding for a 5 year period is requested; earlier funding awards for periods
of 2 years has not been conducive to long term planning and strategy. The costs of brain banking in the UK compare very
favourably with those in Europe and in the USA; over the next 5 years the banks will continue to work to improve efficiency
of operation and to operate a cost recovery programme in keeping with MRC</gtr:technicalSummary><gtr:potentialImpactText>The activities of the brain banks will be of major significance to neuroscience researchers in the UK and the banks plan to
capitalise upon this by promoting the availability of their tissue samples during the course of this grant, primarily by the
MRC database, which will give details of all samples currently available, including control samples. This promotion will not
be confined to academic researchers, but also through the Association of British Pharmaceutical Industries the applicants
will promote the availability of the tissue samples in their banks and will engage with both academic and industrial
researchers to help provide the samples they require.
The brain banks already supply tissue samples to commercial companies for their research and development purposes and
it is planned to continue and develop these contacts within an appropriate framework.
The applicants are involved in a number of local, national and international committees and bodies that relate to research.
Policymakers within both government (DH) and non-governmental organisations and regulators (e.g. the Human Tissue
Authority) will benefit from information arising from the use of human brain tissue samples and also from the general
promotion of brain donation in neuroscience research.
The applicants have previously engaged with museums (including the Wellcome Trust museum) and charities including the
Alzheimer's Society, Alzheimer's Research UK, the Multiple Sclerosis Society and Parkinson's UK to provide expert advice
on brain banking. The applicants also work within the committee structure of these charities to advise on their research
activities, particularly those that might involve the collection and use of human tissue samples.
The wider public is likely to benefit from this planned research, particularly if the tissue samples provided result in improved
diagnosis or treatment for patients with neurodegenerative disorders. Furthermore, the promotion of brain banking and the
value of brain donation for research will help raise public awareness of the challenges of dementia and neurodegenerative
diseases, and help make individuals take an informed choice on this complex matter.
It is likely that the government may benefit from this research, particularly in respect to the activities of the Ministerial Action
Group on Dementia Research and the Prime Minister's Challenge on dementia, within which brain banking is
acknowledged as an essential requirement to support researchers in this field. The support requested in this application
will be of wider benefit to these government initiatives and the research arising from this work, supported by other
government funded bodies including NIHR.
Finally, MRC is likely to benefit from this research, since the applicants already provide large numbers of tissue samples to
researchers such as Professor John Hardy, UCL, who are in receipt of significant funding from MRC to undertake research
projects that are critically dependent on a continuous supply of high quality tissue samples that will be collected and made
available during the course of this proposal.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1229498</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Brains for Dementia Research</gtr:description><gtr:id>CAAC67C7-C100-446C-926C-5A33047ECF64</gtr:id><gtr:impact>Increased numbers of brain donors, who will have thourough clinical assesments prior to donation.</gtr:impact><gtr:outcomeId>nJs1aTHB9xw-4</gtr:outcomeId><gtr:partnerContribution>Collaborative research projects, sharing of tissueCollaborative Research projects and sharing of tissueCollaborative research projects and sharing of tissueCollaborative research projects and sharing of tissue</gtr:partnerContribution><gtr:piContribution>Projects are ongoing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute for Ageing and Health</gtr:department><gtr:description>Brains for Dementia Research</gtr:description><gtr:id>FD26A327-3149-48D5-9074-9066B6CB935E</gtr:id><gtr:impact>Increased numbers of brain donors, who will have thourough clinical assesments prior to donation.</gtr:impact><gtr:outcomeId>nJs1aTHB9xw-3</gtr:outcomeId><gtr:partnerContribution>Collaborative research projects, sharing of tissueCollaborative Research projects and sharing of tissueCollaborative research projects and sharing of tissueCollaborative research projects and sharing of tissue</gtr:partnerContribution><gtr:piContribution>Projects are ongoing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Brains for Dementia Research</gtr:description><gtr:id>2692B8ED-AA40-4F77-9AC3-D36377477202</gtr:id><gtr:impact>Increased numbers of brain donors, who will have thourough clinical assesments prior to donation.</gtr:impact><gtr:outcomeId>nJs1aTHB9xw-5</gtr:outcomeId><gtr:partnerContribution>Collaborative research projects, sharing of tissueCollaborative Research projects and sharing of tissueCollaborative research projects and sharing of tissueCollaborative research projects and sharing of tissue</gtr:partnerContribution><gtr:piContribution>Projects are ongoing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Oxford Centre for Human Brain Activity (OHBA)</gtr:department><gtr:description>Brains for Dementia Research</gtr:description><gtr:id>A7E19485-190B-4F07-B056-4921551F8FBF</gtr:id><gtr:impact>Increased numbers of brain donors, who will have thourough clinical assesments prior to donation.</gtr:impact><gtr:outcomeId>nJs1aTHB9xw-2</gtr:outcomeId><gtr:partnerContribution>Collaborative research projects, sharing of tissueCollaborative Research projects and sharing of tissueCollaborative research projects and sharing of tissueCollaborative research projects and sharing of tissue</gtr:partnerContribution><gtr:piContribution>Projects are ongoing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Community-Based Medicine</gtr:department><gtr:description>Brains for Dementia Research</gtr:description><gtr:id>7BC4BD8E-8E15-45D4-A7FF-36BC3E313577</gtr:id><gtr:impact>Increased numbers of brain donors, who will have thourough clinical assesments prior to donation.</gtr:impact><gtr:outcomeId>nJs1aTHB9xw-1</gtr:outcomeId><gtr:partnerContribution>Collaborative research projects, sharing of tissueCollaborative Research projects and sharing of tissueCollaborative research projects and sharing of tissueCollaborative research projects and sharing of tissue</gtr:partnerContribution><gtr:piContribution>Projects are ongoing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Pint of Science talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F6A53D7D-6396-4BE2-A1ED-C4506286E581</gtr:id><gtr:impact>Team member gave a talk for the 'Pint of Science' series in a London pub to approx. 50 people</gtr:impact><gtr:outcomeId>58de6715c3a911.91752135</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>55491BA4-BA6A-4888-9563-C1DF5E024E89</gtr:id><gtr:impact>increased awareness of research

n/a</gtr:impact><gtr:outcomeId>546225ebe97472.28517459</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public awareness day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7BEEB976-E974-475A-AD7E-B4F97953AFB3</gtr:id><gtr:impact>lots of interesting questions asked

n/a</gtr:impact><gtr:outcomeId>546227e2c0e6b0.75871492</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1229499</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC London Neurodegenerative Diseases Brain Bank</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>7FADE222-43A6-487D-AE5F-BA47758C5899</gtr:id><gtr:outcomeId>s9UcsrRGufF</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Database of all tissue held in the UK Brain bank network - searchable by registered users</gtr:description><gtr:id>C338F6B0-8E43-4256-B01D-EB41E75A59F1</gtr:id><gtr:impact>Increased accessibility to tissue</gtr:impact><gtr:outcomeId>58de68384a3059.67553946</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>MRC brainbank tissue database</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>https://www.mrc.ac.uk/research/facilities-and-resources-for-researchers/brain-banks/</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>92A21819-B4EB-4C10-A2A2-88C530E8CC46</gtr:id><gtr:title>Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46e73b422d17d863d689d21fb0a952eb"><gtr:id>46e73b422d17d863d689d21fb0a952eb</gtr:id><gtr:otherNames>Kun-Rodrigues C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58db930f88aef4.00744299</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1311C27-9BAD-4157-B6F6-FAFD102CC994</gtr:id><gtr:title>Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18061332c54aaf54ab04a4a898d17ccc"><gtr:id>18061332c54aaf54ab04a4a898d17ccc</gtr:id><gtr:otherNames>Gomez-Deza J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>58db9435134e97.43882322</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C236E86C-E626-4447-8A2D-9E8E6F3DABBC</gtr:id><gtr:title>Retention of hexanucleotide repeat-containing intron in C9orf72 mRNA: implications for the pathogenesis of ALS/FTD.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52940ec2fe08219598d16e61c9f32c80"><gtr:id>52940ec2fe08219598d16e61c9f32c80</gtr:id><gtr:otherNames>Niblock M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>58db93123291b0.67759880</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FC049EC-208B-44E9-BB83-07CD8BE1437B</gtr:id><gtr:title>Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90509523adb96ea1aa3696ac87c9450d"><gtr:id>90509523adb96ea1aa3696ac87c9450d</gtr:id><gtr:otherNames>Smith BN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>54621f8365a556.38826641</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1C518FA-685C-47E7-A7BE-B31BB262030B</gtr:id><gtr:title>C9orf72 poly GA RAN-translated protein plays a key role in amyotrophic lateral sclerosis via aggregation and toxicity.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c831250c6d5af43302dbd12e99b4fb6"><gtr:id>1c831250c6d5af43302dbd12e99b4fb6</gtr:id><gtr:otherNames>Lee YB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5aa93f387c1ac8.42400502</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73E25ED7-0531-465F-AD96-5CCB070C71D5</gtr:id><gtr:title>In vitro prion-like behaviour of TDP-43 in ALS.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f81eaa813c262feb0e690df5c6269148"><gtr:id>f81eaa813c262feb0e690df5c6269148</gtr:id><gtr:otherNames>Smethurst P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>58db930f57e848.89148102</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0287796-8F80-4A24-9659-8490F9587F89</gtr:id><gtr:title>ALS-FUS pathology revisited: singleton FUS mutations and an unusual case with both a FUS and TARDBP mutation.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/260fa42b858aee5033974fabe5a89dd6"><gtr:id>260fa42b858aee5033974fabe5a89dd6</gtr:id><gtr:otherNames>King A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>58db94348cd9b0.39910061</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A904716-E9F0-44D1-A0F2-ADB94D3A3D13</gtr:id><gtr:title>ABCA7 p.G215S as potential protective factor for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc6f5d980b9f26a631bb27b333a684ff"><gtr:id>fc6f5d980b9f26a631bb27b333a684ff</gtr:id><gtr:otherNames>Sassi C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58db93113dea19.82116291</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71AD599E-6D65-4B6B-B3A3-57F336276600</gtr:id><gtr:title>Proteomic analyses reveal that loss of TDP-43 affects RNA processing and intracellular transport.</gtr:title><gtr:parentPublicationTitle>Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a68fd5b1ddbc5cb477a04d8d9b44b0b"><gtr:id>3a68fd5b1ddbc5cb477a04d8d9b44b0b</gtr:id><gtr:otherNames>?talekar M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0306-4522</gtr:issn><gtr:outcomeId>58db94362a9545.16286078</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D545FE96-E141-438B-8266-301B70A47A47</gtr:id><gtr:title>Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e4d0cac119354bd44fe812e64bb8a75"><gtr:id>2e4d0cac119354bd44fe812e64bb8a75</gtr:id><gtr:otherNames>Tiwari SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>58db930fb42743.72515288</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A443B770-CC5C-47B9-8147-53491311A80B</gtr:id><gtr:title>Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b237e1dd0d5ded53e55bf78ceb3cb1b3"><gtr:id>b237e1dd0d5ded53e55bf78ceb3cb1b3</gtr:id><gtr:otherNames>Davidson YS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>54621ae269af06.40132454</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AFE0CEF-A7A4-4406-9E6F-58B815579AB7</gtr:id><gtr:title>Genetic compendium of 1511 human brains available through the UK Medical Research Council Brain Banks Network Resource.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/014f62366555b270d7daae3cc0c9f4da"><gtr:id>014f62366555b270d7daae3cc0c9f4da</gtr:id><gtr:otherNames>Keogh MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>58db930e7963a4.48753769</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39783BDB-C76E-406B-940E-51A00D8410B9</gtr:id><gtr:title>Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56b2d14505f1916bc463c5643c1c28d8"><gtr:id>56b2d14505f1916bc463c5643c1c28d8</gtr:id><gtr:otherNames>Guerreiro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>5aa91d1a93b9d2.46052622</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6FE1CC2-0D1B-494B-9B4E-0AF2DC705FE1</gtr:id><gtr:title>Which ante mortem clinical features predict progressive supranuclear palsy pathology?</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7a435c099f51c22c978c2952fedec72"><gtr:id>f7a435c099f51c22c978c2952fedec72</gtr:id><gtr:otherNames>Respondek G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>5aa93ffc164358.32892025</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C6FB943-F8DC-4A79-A3E8-8798F2F3A6FC</gtr:id><gtr:title>Clusterin expression is upregulated following acute head injury and localizes to astrocytes in old head injury.</gtr:title><gtr:parentPublicationTitle>Neuropathology : official journal of the Japanese Society of Neuropathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddda41cb956f24e278d3fa4457b83ecb"><gtr:id>ddda41cb956f24e278d3fa4457b83ecb</gtr:id><gtr:otherNames>Troakes C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0919-6544</gtr:issn><gtr:outcomeId>58db9310670ed1.87987300</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEA6664B-6D15-40D9-A577-7D34CF84CF56</gtr:id><gtr:title>Variation in 5-hydroxymethylcytosine across human cortex and cerebellum.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/878e2d05b1e177f10ea100a84346398f"><gtr:id>878e2d05b1e177f10ea100a84346398f</gtr:id><gtr:otherNames>Lunnon K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>58db94328d0a90.99654685</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50283699-3C70-4E8A-9784-712A1E37A878</gtr:id><gtr:title>Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90509523adb96ea1aa3696ac87c9450d"><gtr:id>90509523adb96ea1aa3696ac87c9450d</gtr:id><gtr:otherNames>Smith BN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>5aa93ffc6dec20.08674914</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2FE9745-38C9-416C-BE90-60F9586C6ECD</gtr:id><gtr:title>Unusual neuropathological features and increased brain aluminium in a resident of Camelford, UK.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/260fa42b858aee5033974fabe5a89dd6"><gtr:id>260fa42b858aee5033974fabe5a89dd6</gtr:id><gtr:otherNames>King A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>5aa93ffbb71827.89367899</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37EEE96C-2D82-4298-9E8C-03E979A95996</gtr:id><gtr:title>Assessment of the degree of asymmetry of pathological features in neurodegenerative diseases. What is the significance for brain banks?</gtr:title><gtr:parentPublicationTitle>Journal of neural transmission (Vienna, Austria : 1996)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/260fa42b858aee5033974fabe5a89dd6"><gtr:id>260fa42b858aee5033974fabe5a89dd6</gtr:id><gtr:otherNames>King A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-9564</gtr:issn><gtr:outcomeId>58db943562b5d5.22148245</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6B6BC8E-559D-409A-A037-56E575926ADD</gtr:id><gtr:title>Tissue-specific patterns of allelically-skewed DNA methylation.</gtr:title><gtr:parentPublicationTitle>Epigenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7b52dfa2214239ad8f998a9194da81c"><gtr:id>a7b52dfa2214239ad8f998a9194da81c</gtr:id><gtr:otherNames>Marzi SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1559-2294</gtr:issn><gtr:outcomeId>58db9432e754c2.55061662</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60DC174E-AFC6-4D77-BAD9-F234807A46B1</gtr:id><gtr:title>Depression and synaptic zinc regulation in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia.</gtr:title><gtr:parentPublicationTitle>The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373ede94ea3c44d7eca786be0b2c1d90"><gtr:id>373ede94ea3c44d7eca786be0b2c1d90</gtr:id><gtr:otherNames>Whitfield DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1064-7481</gtr:issn><gtr:outcomeId>5462193f64eff5.80492797</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AB49E47-8647-4605-BEFC-BC99A106E37D</gtr:id><gtr:title>Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/609865d4dd5b805590a0ed599a30249b"><gtr:id>609865d4dd5b805590a0ed599a30249b</gtr:id><gtr:otherNames>Bras J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>54621bdaf16d89.67779903</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A6F9956-E04C-4A30-885C-45989AA13D57</gtr:id><gtr:title>The CHCHD10 P34S variant is not associated with ALS in a UK cohort of familial and sporadic patients.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a1becffcc1571868d22b707ce216d4c"><gtr:id>5a1becffcc1571868d22b707ce216d4c</gtr:id><gtr:otherNames>Wong CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58db9434c82d84.62812802</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57142826-79A9-49A5-91B1-6CCE26071854</gtr:id><gtr:title>NEK1 variants confer susceptibility to amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa8dc20d96363a2f4e574a132c76feaf"><gtr:id>aa8dc20d96363a2f4e574a132c76feaf</gtr:id><gtr:otherNames>Kenna KP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58db93102fe8b5.25283602</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>137936ED-0A18-4FC1-9F20-AFB8A252D1A3</gtr:id><gtr:title>Gamma-synuclein pathology in amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Annals of clinical and translational neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd53cac0abf325e035a3f235ae534c0a"><gtr:id>fd53cac0abf325e035a3f235ae534c0a</gtr:id><gtr:otherNames>Peters OM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2328-9503</gtr:issn><gtr:outcomeId>58db94371236d1.48488495</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18602FAB-F16D-4DFA-ABA2-425C4A43DEB8</gtr:id><gtr:title>Novel mutations support a role for Profilin 1 in the pathogenesis of ALS.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90509523adb96ea1aa3696ac87c9450d"><gtr:id>90509523adb96ea1aa3696ac87c9450d</gtr:id><gtr:otherNames>Smith BN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58db9437da6319.62298473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE43D0F9-F1C1-4999-B984-D59B66F4F96C</gtr:id><gtr:title>The Identification of Aluminum in Human Brain Tissue Using Lumogallion and Fluorescence Microscopy.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90b2074f1fe9a5ca4a0b13a591e9efd5"><gtr:id>90b2074f1fe9a5ca4a0b13a591e9efd5</gtr:id><gtr:otherNames>Mirza A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>58db930f250f28.08177539</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F18CC41-F7E6-4F2A-BA60-D321DE7FB8FA</gtr:id><gtr:title>Aluminium in brain tissue in familial Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90b2074f1fe9a5ca4a0b13a591e9efd5"><gtr:id>90b2074f1fe9a5ca4a0b13a591e9efd5</gtr:id><gtr:otherNames>Mirza A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0946-672X</gtr:issn><gtr:outcomeId>58db930dbeff96.49943160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>965D27B9-4D29-4E8C-B80C-8B2B0EBD940D</gtr:id><gtr:title>Genome-wide significant schizophrenia risk variation on chromosome 10q24 is associated with altered cis-regulation of BORCS7, AS3MT, and NT5C2 in the human brain.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d182f9c5c19fb926bfa186a131dc784"><gtr:id>7d182f9c5c19fb926bfa186a131dc784</gtr:id><gtr:otherNames>Duarte RRR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>58db931206a5c5.76647899</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6C038C8-478C-462C-8FB1-2C20240AA4E3</gtr:id><gtr:title>Evidence that the presynaptic vesicle protein CSPalpha is a key player in synaptic degeneration and protection in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Molecular brain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e4d0cac119354bd44fe812e64bb8a75"><gtr:id>2e4d0cac119354bd44fe812e64bb8a75</gtr:id><gtr:otherNames>Tiwari SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1756-6606</gtr:issn><gtr:outcomeId>58db943742ad43.85802910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CB6CAF3-8625-441D-8D09-A5E18CFD7A27</gtr:id><gtr:title>Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP-43 pathology and not associated with aggregated forms of dipeptide repeat proteins.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd1ac80b42e880cbd4857157a6fb016d"><gtr:id>dd1ac80b42e880cbd4857157a6fb016d</gtr:id><gtr:otherNames>Davidson Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>58db9433b95701.35768103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08B684E1-A60A-494A-9CC6-0CE8E47FA832</gtr:id><gtr:title>Control tissue in brain banking: the importance of thorough neuropathological assessment.</gtr:title><gtr:parentPublicationTitle>Journal of neural transmission (Vienna, Austria : 1996)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9963f5dfef08ff2e5046f8167ff09f18"><gtr:id>9963f5dfef08ff2e5046f8167ff09f18</gtr:id><gtr:otherNames>Nolan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-9564</gtr:issn><gtr:outcomeId>58db9436b3c226.52524225</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7E5AC8D-3658-46EE-8250-AE8BE54F766A</gtr:id><gtr:title>A comparison of mitochondrial DNA isolation methods in frozen post-mortem human brain tissue--applications for studies of mitochondrial genetics in brain disorders.</gtr:title><gtr:parentPublicationTitle>BioTechniques</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2e3c28d30fd7f5224a384b7f7c3280d"><gtr:id>d2e3c28d30fd7f5224a384b7f7c3280d</gtr:id><gtr:otherNames>Devall M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0736-6205</gtr:issn><gtr:outcomeId>58db9434431148.16434961</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C467191E-E018-4FEE-858E-A417DA44DDFD</gtr:id><gtr:title>Oligogenic genetic variation of neurodegenerative disease genes in 980 postmortem human brains.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/014f62366555b270d7daae3cc0c9f4da"><gtr:id>014f62366555b270d7daae3cc0c9f4da</gtr:id><gtr:otherNames>Keogh MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5aa91d1a4da019.58814657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16D0E99B-6579-449D-9D38-672D0C62AEBD</gtr:id><gtr:title>Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56b2d14505f1916bc463c5643c1c28d8"><gtr:id>56b2d14505f1916bc463c5643c1c28d8</gtr:id><gtr:otherNames>Guerreiro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58db9433357043.62478294</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6173A922-518B-443D-8C46-5A32CAD652BF</gtr:id><gtr:title>Lack of association between TDP-43 pathology and tau mis-splicing in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52940ec2fe08219598d16e61c9f32c80"><gtr:id>52940ec2fe08219598d16e61c9f32c80</gtr:id><gtr:otherNames>Niblock M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58db9433ec7352.74840642</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3F1A32D-8339-488C-9C55-4A425841594D</gtr:id><gtr:title>Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a7bfa806ecaa3aa93efd2103aa2e758"><gtr:id>0a7bfa806ecaa3aa93efd2103aa2e758</gtr:id><gtr:otherNames>Cirulli ET</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>58db9436697046.12768477</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3290C666-9F34-408C-BC6D-3C18B36775D7</gtr:id><gtr:title>Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a439e3cead6e102b8a7c8e439170b4fb"><gtr:id>a439e3cead6e102b8a7c8e439170b4fb</gtr:id><gtr:otherNames>Wei W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>58db930e1493d5.88214657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B3E2D1A-DB12-49CA-983F-1612EF0AC1BD</gtr:id><gtr:title>Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73a8bd121700732d13322b944eaf8dff"><gtr:id>73a8bd121700732d13322b944eaf8dff</gtr:id><gtr:otherNames>Hannon E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>58db9433881e53.80182260</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85BEE086-9F71-4335-B3C9-BDC5CD61F44B</gtr:id><gtr:title>Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson's disease brain.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6aab41c64ffd043a2af7978329fd334"><gtr:id>a6aab41c64ffd043a2af7978329fd334</gtr:id><gtr:otherNames>Trist BG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>5aa93ffbe3f087.53388510</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2C936BF-92C6-4BA7-AF10-C5938C2E0C41</gtr:id><gtr:title>On the identification of low allele frequency mosaic mutations in the brains of Alzheimer's disease patients.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcdad216ec928b21b8608a8e39b74026"><gtr:id>bcdad216ec928b21b8608a8e39b74026</gtr:id><gtr:otherNames>Sala Frigerio C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>58db94359bd582.46959532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBEFDE42-A537-4598-86C3-DBFC3236C4DA</gtr:id><gtr:title>Agonist and antagonist bind differently to 5-HT1A receptors during Alzheimer's disease: A post-mortem study with PET radiopharmaceuticals.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/761359f3f7fbaff4c99cbe26f80ed1b9"><gtr:id>761359f3f7fbaff4c99cbe26f80ed1b9</gtr:id><gtr:otherNames>Vidal B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>58db93119bd797.44705015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2D5A88A-FCA0-400D-A8CD-E11879AF468A</gtr:id><gtr:title>Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer's disease progression: CX3CL1, TREM2, and PPAR?.</gtr:title><gtr:parentPublicationTitle>Journal of neural transmission (Vienna, Austria : 1996)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0ad4e84d65dad22eb32a52aa7530c3f"><gtr:id>d0ad4e84d65dad22eb32a52aa7530c3f</gtr:id><gtr:otherNames>Strobel S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-9564</gtr:issn><gtr:outcomeId>58db94379e9ca3.26713580</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>750D1055-D8BC-405F-B5F0-B468B2094D19</gtr:id><gtr:title>APOE e4 is also required in TREM2 R47H variant carriers for Alzheimer's disease to develop.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d725c4bae72a721d2f442f9cae44bac"><gtr:id>8d725c4bae72a721d2f442f9cae44bac</gtr:id><gtr:otherNames>Murray CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>5aa91d1a1f7b67.83550702</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A4B42E2-D648-45F0-867A-DE03DB54D58E</gtr:id><gtr:title>Influence of Coding Variability in APP-A? Metabolism Genes in Sporadic Alzheimer's Disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc6f5d980b9f26a631bb27b333a684ff"><gtr:id>fc6f5d980b9f26a631bb27b333a684ff</gtr:id><gtr:otherNames>Sassi C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58db93116bb280.55118471</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73E5AD9F-06F7-43E1-A9CF-BF1B807A7757</gtr:id><gtr:title>Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e75e3b3ba79991d679d14b7a06170f9b"><gtr:id>e75e3b3ba79991d679d14b7a06170f9b</gtr:id><gtr:otherNames>Kurbatskaya K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>58db9311c90b05.34891302</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9C4E729-33A1-4C9D-A3C8-FE4384492FA7</gtr:id><gtr:title>Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e92699e66f262cd182ee6581ab96aae"><gtr:id>5e92699e66f262cd182ee6581ab96aae</gtr:id><gtr:otherNames>H?glinger GU</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>5aa93ffd3a5d29.87563185</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3228F51E-949B-4297-966A-F12C95D4A6A3</gtr:id><gtr:title>Extended post-mortem delay times should not be viewed as a deterrent to the scientific investigation of human brain tissue: a study from the Brains for Dementia Research Network Neuropathology Study Group, UK.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b25414b7949c1dc388472b22a5fd011"><gtr:id>7b25414b7949c1dc388472b22a5fd011</gtr:id><gtr:otherNames>Robinson AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>58db930ea85e81.31688904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8E6A314-70FD-4B55-B210-6C180B415FCB</gtr:id><gtr:title>Erratum to: Variation in 5-hydroxymethylcytosine across human cortex and cerebellum.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/878e2d05b1e177f10ea100a84346398f"><gtr:id>878e2d05b1e177f10ea100a84346398f</gtr:id><gtr:otherNames>Lunnon K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>58db931110a9f6.72018899</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43FE3A7A-EBB1-47FE-A928-BD58C7DBD80A</gtr:id><gtr:title>Schizophrenia-associated methylomic variation: molecular signatures of disease and polygenic risk burden across multiple brain regions.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6db2fe278c34aa6de97b6a6e12cafcdb"><gtr:id>6db2fe278c34aa6de97b6a6e12cafcdb</gtr:id><gtr:otherNames>Viana J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>58db930e47d068.86466232</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E4D6ED5-6107-4CDF-9B96-7A924EE265ED</gtr:id><gtr:title>Stratified gene expression analysis identifies major amyotrophic lateral sclerosis genes.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/189b1ab3fec05c8e5670388f3356335d"><gtr:id>189b1ab3fec05c8e5670388f3356335d</gtr:id><gtr:otherNames>Jones AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58db9435ea4452.43209860</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/L016397/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>